Comar To Offer CR Closure For Imidazoline-Containing Products
Published: July 2nd, 2013
Comar is developing the SecureCap Child-Resistant (CR) Closure in response to the Consumer Product Safety Commission’s (CPSC) rule requiring child-resistant packaging for products containing the equivalent of 0.08 milligrams or more of imidazoline.
Comar has offered the SecureCap with a cut out in the cap’s center for dropper assemblies. The CR dropper caps are currently standard stocked items in 20mm, 24mm and 28mm sizes.
The new line is being developed for ophthalmic and nasal applications and features a solid cap, with 13mm and 15mm sizes for ophthalmic, and 15mm and 18mm for nasal.
The SecureCap CR closure uses Comar's existing two-piece push-and-turn technology with proven CR and senior-friendly effectiveness, the company said.
CPSC mini protocol tests were completed with positive results in mid-May 2013 with a full protocol to follow, and commercialization expected later this year. Various sample sizes are now available, the company said.
SecureCap Child-Resistant Closures are patent pending and will be CE marked. System components are manufactured in facilities that comply with current Good Manufacturing Practices (cGMP) and ISO 9001:13485 quality standards, the company said.